{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-058513","form_type":"8-K","ticker":"LENZ","cik":"0001815776","company_name":"LENZ Therapeutics, Inc.","filed_at":"2024-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.649339+00:00","generated_at":"2026-06-05T03:59:47.178052+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Graphite Bio discloses supplemental proxy details to resolve merger-related shareholder lawsuits","bullets":["Two federal lawsuits filed in CA and DE allege proxy omissions on LENZ financials, advisor conflicts; 12 additional demand letters received.","Company voluntarily adds disclosures including Transaction Committee member compensation ($0 extra) and liquidation value of $2.86/sh in Feb 2024.","Liquidation analysis per share in March 2027: $0.10 low case, $0.19 high case based on $5.6M-$11.1M net cash.","Leerink DCF analysis yielded implied exchange ratio range of 2.8075-3.2957, valuing LENZ equity at $460M-$540M.","Graphite denies allegations, states proxy complies with law; no executive officers expected to serve in combined company post-merger."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-058513","json":"https://secwatch.observer/filing/0001193125-24-058513.json","markdown":"https://secwatch.observer/filing/0001193125-24-058513.md","text":"https://secwatch.observer/filing/0001193125-24-058513.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815776/000119312524058513/0001193125-24-058513-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815776/000119312524058513/d772578d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T03:59:47.178052+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}